Topic

Tagrisso (osimertinib)

A collection of 28 issues

How to Get Tagrisso (osimertinib) Covered by UnitedHealthcare in Texas: Prior Authorization Guide, Appeals Process, and Medical Necessity Requirements

Answer Box: Getting Tagrisso Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Tagrisso (osimertinib) based on documented EGFR-mutant NSCLC and FDA-approved indications. In Texas, you have 180 days to appeal denials internally, then 4 months for external review. Fastest path: Have your oncologist submit PA through the UHC
5 min read

How to Get Tagrisso (Osimertinib) Covered by UnitedHealthcare in Michigan: Appeals Guide & Formulary Alternatives

Quick Answer: Getting Tagrisso Covered by UnitedHealthcare in Michigan UnitedHealthcare typically covers Tagrisso (osimertinib) as a Tier 3 specialty drug requiring prior authorization for EGFR-mutant NSCLC. First step: Have your oncologist submit PA documentation including EGFR mutation test results, staging, and medical necessity letter through the UnitedHealthcare provider portal. If
5 min read

How to Get Tagrisso (osimertinib) Covered by Humana in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tagrisso (osimertinib) Covered by Humana in California Humana requires prior authorization for Tagrisso (osimertinib) with documented EGFR mutation testing and clinical justification. The fastest path: have your oncologist submit a complete prior authorization request through Humana's provider portal with EGFR test results, treatment history, and
7 min read

If Tagrisso (Osimertinib) Isn't Approved by Blue Cross Blue Shield in Michigan: Formulary Alternatives & Exception Paths

Answer Box: Getting Tagrisso Alternatives or Exceptions with BCBS Michigan If BCBS Michigan denies Tagrisso (osimertinib), you have three main paths: try formulary alternatives like erlotinib or gefitinib with prior authorization, request a formulary exception for Tagrisso with medical necessity documentation, or appeal the denial through Michigan's external
5 min read

Getting Tagrisso (Osimertinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tagrisso Covered by BCBS North Carolina Fastest Path: Tagrisso (osimertinib) requires prior authorization from Blue Cross Blue Shield of North Carolina for EGFR-mutant NSCLC. Your oncologist must document EGFR mutation testing (exon 19 deletion or L858R), disease staging, and any prior TKI failures. Submit PA via CoverMyMeds
6 min read

UnitedHealthcare's Coverage Criteria for Tagrisso (osimertinib) in Pennsylvania: What Counts as "Medically Necessary"?

Answer Box: Getting Tagrisso Covered by UnitedHealthcare in Pennsylvania To get Tagrisso (osimertinib) covered by UnitedHealthcare in Pennsylvania, you need: documented EGFR mutation (exon 19 deletion or L858R), confirmed NSCLC diagnosis, and prior authorization approval. Submit through the UHC Provider Portal with pathology reports and staging documentation. If denied, Pennsylvania&
5 min read

How to Get Tagrisso (osimertinib) Covered by Blue Cross Blue Shield in California: Prior Authorization Forms, Appeal Process & Success Strategies

Answer Box: Getting Tagrisso Covered in California Blue Cross Blue Shield plans in California require prior authorization for Tagrisso (osimertinib) with documented EGFR mutations in NSCLC. Submit electronically via CoverMyMeds or the plan's provider portal with pathology reports showing EGFR testing results. If denied, file an internal appeal
6 min read